A comparative study on serum lipoprotein (a) and lipid profile between rheumatoid arthritis patients and normal subjects

Journal of Pharmacy and Bioallied Sciences

Volumn 7, Issue , 2015, Pages S22-S25

  Shiva Govindan, K P ^a   Basha, Saleem ^a   Ramesh, V ^b   Kumar, C Naveen ^b   Swathi, S ^c  

^a Melmaruvathur Adhiparasakthi Institute of Medical Sciences and Research   (India)

^b Affiliated to Bharath University   (India)

^c Madha Dental College   (India)

Author keywords

Cardiovascular disease; lipid profile; lipoprotein (a); rheumatoid arthritis

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; HIGH RISK PATIENT; HUMAN; LIPID COMPOSITION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84928946486     PISSN: None     EISSN: 09757406     Source Type: Journal    
DOI: 10.4103/0975-7406.155767     Document Type: Article

References (29)

1. Solomon DH, Goodson NJ, Katz JN, Weinblatt ME, Avorn J, Setoguchi S, et al. Patterns of cardiovascular risk in rheumatoid arthritis. Ann Rheum Dis 2006;65:1608-12.
2. Sattar N, McCarey DW, Capell H, McInnes IB. Explaining how "highgrade" systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 2003;108:2957-63.
3. Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA, et al. The mortality of rheumatoid arthritis. Arthritis Rheum 1994;37:481-94.
4. Enas EA, Garg A, Davidson MA, Nair VM, Huet BA, Yusuf S. Coronary heart disease and its risk factors in firstgeneration immigrant Asian Indians to the United States of America. Indian Heart J 1996;48:343-53.
5. AnglesCano E, de la Peña Díaz A, Loyau S. Inhibition of fibrinolysis by lipoprotein (a). Ann N Y Acad Sci 2001;936:261-75.
6. Gardner CD, Fortmann SP, Krauss RM. Association of small lowdensity lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA 1996;276:875-81.
7. Banoo H. Role of dyslipidaemia in cardiovascular diseases and the therapeutic benefits by the appropriate drugs. Rev Artic Orion 2001;8: 76-85.
8. Angeline T, Aruna R, Ramadevi K, Mohan G, Jeyaraj N. Serum lipoprotein (a) and lipid profile in young South Indian patients with myocardial infarction. Indian J Clin Biochem 2003;18:103-6.
9. Dahlen GH. Lipoprotein (a) in relation to atherosclerotic diseases. In: Widhalm K, Naito HK, editors. Prog Clin Biol Res 1988;255:27-36.
10. Danesh J, Collins R, Peto R. Lipoprotein (a) and coronary heart disease. Metaanalysis of prospective studies. Circulation 2000;102:1082-5.
11. Rantapaa?Dahlqvist S, Wallberg?Jonsson S, Dahlén G. Lipoprotein (a), lipids, and lipoproteins in patients with rheumatoid arthritis. Ann Rheum Dis 1991;50:366-8.
12. Ehnholm C, Garoff H, Renkonen O, Simons K. Protein and carbohydrate composition of Lp (a) lipoprotein from human plasma. Biochemistry 1972;11:3229-32.
13. Ross R. Atherosclerosis-An inflammatory disease. N Engl J Med 1999;340:115-26.
14. Dursunoglu D, Evrengül H, Polat B, Tanriverdi H, Cobankara V, Kaftan A, et al. Lp (a) lipoprotein and lipids in patients with rheumatoid arthritis: Serum levels and relationship to inflammation. Rheumatol Int 2005;25:241-5.
15. Lazarevic MB, Vitic J, Myones BL, Mladenovic V, Nanusevic N, Skosey JL, et al. Antilipoprotein antibodies in rheumatoid arthritis. Semin Arthritis Rheum 1993;22:385-91.
16. Lakatos J, Hárságyi A. Serum total, HDL, LDL cholesterol, and triglyceride levels in patients with rheumatoid arthritis. Clin Biochem 1988;21:93-6.
17. Tsimikas S, Brilakis ES, Miller ER, McConnell JP, Lennon RJ, Kornman KS, et al. Oxidized phospholipids, Lp (a) lipoprotein, and coronary artery disease. N Engl J Med 2005;353:46-57.
18. Feric NT, Boffa MB, Johnston SM, Koschinsky ML. Apolipoprotein (a) inhibits the conversion of Gluplasminogen to Lysplasminogen: A novel mechanism for lipoprotein (a)mediated inhibition of plasminogen activation. J Thromb Haemost 2008;6:2113-20.
19. Nordestgaard BG, Chapman MJ, Ray K, Borén J, Andreotti F, Watts GF, et al. Lipoprotein (a) as a cardiovascular risk factor: Current status. Eur Heart J 2010;31:2844-53.
20. McEntegart A, Capell HA, Creran D, Rumley A, Woodward M, Lowe GD. Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis. Rheumatology (Oxford). 2001;40:640-4.
21. Briggs C, Pharm D. The relationship between rheumatoid arthritis and heart failure. J Manag Care Med 2011;12:35-40.
22. AgostonColdea L, Rusu LD, Zdrenghea D, Rusu ML, Pop D, Craciun A, et al. Lipoprotein (a) and lipid and nonlipid risk factors in coronaries risk assessment. Rom J Intern Med 2008;46:137-44.
23. Noma A, Abe A, Maeda S, Seishima M, Makino K, Yano Y, et al. Lp (a): An acutephase reactant? Chem Phys Lipids 1994;67-68:411-7.
24. Park YB, Ahn CW, Choi HK, Lee SH, In BH, Lee HC, et al. Atherosclerosis in rheumatoid arthritis: Morphologic evidence obtained by carotid ultrasound. Arthritis Rheum 2002;46:1714-9.
25. Hurt?Camejo E, Paredes S, Masana L, Camejo G, Sartipy P, Rosengren B, et al. Elevated levels of small, low?density lipoprotein with high affinity for arterial matrix components in patients with rheumatoid arthritis: Possible contribution of phospholipase A2 to this atherogenic profile. Arthritis Rheum 2001;44:2761-7.
26. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive summary of the third report of The National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). J Am Med Assoc 2001;285:2486-97.
27. WallbergJonsson S, Cederfelt M, Rantapää Dahlqvist S. Hemostatic factors and cardiovascular disease in active rheumatoid arthritis: An 8 year followup study. J Rheumatol 2000;27:71-5.
28. Nicola PJ, MaraditKremers H, Roger VL, Jacobsen SJ, Crowson CS, Ballman KV, et al. The risk of congestive heart failure in rheumatoid arthritis: A populationbased study over 46 years. Arthritis Rheum 2005;52:412-20.
29. Davis JM 3rd, Roger VL, Crowson CS, Kremers HM, Therneau TM, Gabriel SE. The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population. Arthritis Rheum 2008;58:2603-11.